BEUDAMED
    FDA Adverse Event Injury Summary report: N

    EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE

    MDR report key: 13505469 · Received February 10, 2022

    Report

    Report Number
    8010047-2022-02727
    Event Type
    Injury
    Date Received
    February 10, 2022
    Date of Event
    January 9, 2022
    Report Date
    February 10, 2022
    Manufacturer
    OLYMPUS MEDICAL SYSTEMS CORP.
    Product Code
    FDS
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    PL
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    THE SUBJECT DEVICE HAS NOT BEEN RETURNED AND THE INVESTIGATION HAS BEEN COMPLETED. THE DHR FOR THIS DEVICE COULD NOT BE REVIEWED SINCE NO SERIAL NUMBER WAS PROVIDED. OLYMPUS ONLY SHIPS DEVICES MANUFACTURED ACCORDING TO ALL APPLICABLE PROCEDURES AND MEET FINAL PRODUCT RELEASE CRITERIA. NO ABNORMALITIES WERE FOUND. A DEFINITIVE ROOT CAUSE WAS NOT IDENTIFIED. BASED ON THE AVAILABLE INFORMATION, THE LEGAL MANUFACTURER DETERMINED THE PROBABLE CAUSE OF THE FAILURE IS LIKELY DUE TO A FACTOR OTHER THAN THE MALFUNCTION OF THE SUBJECT DEVICE. NO MALFUNCTION WAS REPORTED.

    Description of Event or Problem · 0

    OLYMPUS REVIEWED THE FOLLOWING LITERATURE ARTICLE: EARLY ENDOSCOPIC TREATMENT OF SYMPTOMATIC PANCREATIC NECROTIC COLLECTIONS BY BY M.JAGIELSKI, J. PIATKOWSKI AND M. JACKOWSKI. ABSTRACT: ENDOSCOPIC ULTRA-SOUND (EUS)-GUIDED TRANSMURAL ENDOSCOPIC DRAINAGE IS COMMONLY USED IN THE TREATMENT OF WALLED OFF PANCREATIC NECROSIS (WOPN) IN THE LATE PHASE OF ACUTE NECROTIC PANCREATITIS (ANP). THE ROLE OF ENDOSCOPIC INTERVENTION REMAINS UNCLEAR IN THE EARLY PHASE OF ANP. THIS STUDY AIMED TO PROSPECTIVELY EVALUATE EARLY ENDOSCOPIC TREATMENT OF ANCS COMPARED WITH ENDOSCOPIC DRAINAGE OF WOPN. OVERALL, 71 PATIENTS WITH ANP WHO UNDERWENT TRANSMURAL ENDOSCOPIC DRAINAGE FOR NECROTIC COLLECTIONS WERE INCLUDED. ENDOSCOPIC INTERVENTION WAS PERFORMED WITHIN THE FIRST FOUR WEEKS OF ANP IN 25 (35.21%) PATIENTS WITH ANC (GROUP 1) AND IN 46 (64.79%) PATIENTS AFTER FOUR WEEKS SINCE THE ONSET OF ANP WITH WOPN (GROUP 2). THE OVERALL MEAN AGE OF PATIENTS WAS 49.9 (22¿79) YEARS AND 59 OF THEM WERE MALES. THE MEAN TIME OF ACTIVE DRAINAGE AND DURATION OF TOTAL ENDOSCOPIC TREATMENT WAS 26.8 AND 16.9 DAYS (P= 0.0001) AND 270.8 AND 164.2 DAYS (P= 0.0001) IN GROUPS 1 AND 2, RESPECTIVELY. THE AVERAGE TOTAL NUMBER OF ENDOSCOPIC INTERVENTIONS WAS 9.5 AND 4.5 IN GROUPS 1 AND 2, RESPECTIVELY (P= 0.0001). THE CLINICAL SUCCESS RATE, FREQUENCY OF COMPLICATIONS OF ENDOSCOPIC INTERVENTIONS, LONG-TERM SUCCESS RATE, AND RECURRENCE RATE WERE NOT SIGNIFICANTLY DIFFERENT BETWEEN THE GROUPS (P> 0.05 FOR EACH). TRANSMURAL ENDOSCOPIC DRAINAGE IS EFFECTIVE METHOD OF TREATMENT OF EARLY ANCS WITHIN THE FIRST FOUR WEEKS OF ANP. HOWEVER, COMPARED WITH ENDOSCOPIC INTERVENTION IN WOPN, MORE INTERVENTIONS AND LONGER DURATION OF DRAINAGE ARE REQUIRED. THE FOLLOWING ADVERSE EVENTS AND MALFUNCTION WAS REPORTED: 10 PATIENTS WITH GASTROINTESTINAL BLEEDING (REQUIRED TRANSFUSIONS). 1 PATIENT WITH GASTROINTESTINAL PERFORATION (TREATED CONSERVATIVELY). LATE COMPLICATIONS OCCURRING MORE THAN 30 DAYS AFTER TREATMENT: 21 NEWLY DIAGNOSED INSULIN-DEPENDENT DIABETES. 25 VENOUS THROMBOSIS (INVOLVING SPLENIC OR PORTAL VEIN). THE AUTHORS REPORTED USE OF 3 OLYMPUS DEVICES. THIS EVENT INCLUDES 3 REPORTS: (B)(6) - OLYMPUS TJF-Q180V. (B)(6) - OLYMPUS GIF-H185 WITH INSUFFLATION OF CO2. (B)(6) - OLYMPUS PBD-234-0806. THIS IS REPORT 2 OF 3 FOR (B)(6) - OLYMPUS GIF-H185 WITH INSUFFLATION OF CO2.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    257903 EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE GASTROINTESTINAL VIDEOSCOPE FDS OLYMPUS MEDICAL SYSTEMS CORP. GIF-H185

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Life Threatening| O| R